Analysis of Buprenorphine/Naloxone Dosing Impact on Treatment Duration, Resource Use and Costs in the Treatment of Opioid-Dependent Adults: A Retrospective Study of US Public and Private Health Care Claims

2014 ◽  
Vol 126 (5) ◽  
pp. 113-120 ◽  
Author(s):  
Amine Khemiri ◽  
Elizaveta Kharitonova ◽  
Vladimir Zah ◽  
Jane Ruby ◽  
Mondher Toumi
Keyword(s):  
Health Care ◽  
Retrospective Study ◽  
Resource Use ◽  
Treatment Duration ◽  
Private Health Care ◽  
Public And Private ◽  
Impact On Treatment ◽  
Health Care Claims

scholarly journals An experimental investigation of mixed systems of public and private health care finance

2012 ◽  
Vol 84 (3) ◽  
pp. 713-729 ◽  
Author(s):  
Neil J. Buckley ◽  
Katherine Cuff ◽  
Jeremiah Hurley ◽  
Logan McLeod ◽  
Stuart Mestelman ◽  
...  
Keyword(s):  
Health Care ◽  
Experimental Investigation ◽  
Private Health Care ◽  
Public And Private ◽  
Health Care Finance ◽  
Mixed Systems

scholarly journals Physician’s sociodemographic profile and distribution across public and private health care: an insight into physicians’ dual practice in Brazil

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Bruno Alonso Miotto ◽  
Aline Gil Alves Guilloux ◽  
Alex Jones Flores Cassenote ◽  
Giulia Marcelino Mainardi ◽  
Giuliano Russo ◽  
...  
Keyword(s):  
Health Care ◽  
Private Health Care ◽  
Dual Practice ◽  
Public And Private ◽  
Sociodemographic Profile ◽  
Insight Into

THE DIFFUSION OF NEW MEDICAL TECHNOLOGIES IN THE PRIVATE SECTOR OF THE U.K. HEALTH CARE SYSTEM

1999 ◽  
Vol 15 (4) ◽  
pp. 619-628
Author(s):  
Yvonne G. Doyle ◽  
R. H. M. McNeilly
Keyword(s):  
Health Care ◽  
Private Sector ◽  
Health Care System ◽  
Medical Technology ◽  
New Technology ◽  
Leading Edge ◽  
Private Health Care ◽  
Public And Private ◽  
Inclusive Approach ◽  
Care System

Eleven percent of the U.K. population holds private health care insurance, and £2.2 billion are spent annually in the acute sector of private health care. Although isolated from policy discussions about new medical technology in the National Health Service, the private sector encounters these interventions regularly. During 18 months in one company, a new medical technology was encountered on average every week; 59 leading edge technologies were submitted for authorization (18 on multiple occasions). There are certain constraints on purchasers of health care in the private sector in dealing with new technology; these include fragmentation of the sector, differing rationalities within companies about limitations on eligibility of new procedures while competing for business, the role and expertise of the medical adviser, and demands of articulate customers. A proactive approach by the private sector to these challenges is hampered by its independence. Poor communication between the public and private sectors, and the lack of a more inclusive approach to policy centrally, undermine the rational diffusion and use of new medical technology in the U.K. health care system.

scholarly journals Direct Costs of Dengue Hospitalization in Brazil: Public and Private Health Care Systems and Use of WHO Guidelines

2014 ◽  
Vol 8 (9) ◽  
pp. e3104 ◽  
Author(s):  
Alessandra A. Vieira Machado ◽  
Anderson Oliveira Estevan ◽  
Antonio Sales ◽  
Kelly Cristina da Silva Brabes ◽  
Júlio Croda ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Systems ◽  
Direct Costs ◽  
Private Health Care ◽  
Who Guidelines ◽  
Public And Private ◽  
Care Systems
Sign in / Sign up

Export Citation Format

Share Document